NYSE
SOLV
Last Price
US $77.15
KEY FIGURES
MKT CAP
$13.8B
EPS
TTM
$8.22
PEG
TTM
0.04x
P/E
TTM
9.69x
P/S
TTM
1.65x
YIELD
0.00%
GROWTH
Revenue Y/Y
Cash Flow (DCF)
Fair Value
Market $77.15
—
Default assumptions
EBITDA Multiple
Fair Value
Market $77.15
2.26%
Default assumptions
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Solventum Corporation cash flow to debt ratio of 7.33% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
Solventum Corporation's free cash flow has decreased -101.24% from $805.00M last year to $-10.00M, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
Solventum Corporation's debt to equity ratio is 1.02, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial stability - Healthy debt to equity ratio development.
Solventum Corporation's debt has decreased relative to shareholder equity from 2.71 last year to 1.02 today, signaling strengthened financials
Financial stability - Net debt/EBITDA.
Solventum Corporation has a net debt to EBITDA ratio of 1.63x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Solventum Corporation's interest coverage ratio of 6.92 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
Solventum Corporation's profit margin has increased (198.67%) in the last year from 5.80% to 17.33%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Solventum Corporation's short-term assets of $3.86G exceed its short-term liabilities of $3.14G
Increasing performance - ROA.
Solventum Corporation's return on assets of 10.16% is higher than the 5.00% threshold, indicating efficient asset utilization
Increasing performance - Absolute return on equity.
Solventum Corporation's return on equity of 30.71%, is higher than 15.00%, indicating good performance
Decreasing performance - Earnings quality.
Solventum Corporation's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Increasing performance - Earnings stability.
Solventum Corporation had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Decreasing performance - Free cash flow.
Solventum Corporation has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Solventum Corporation has negative free cash flow, indicating cash burn
Increasing performance - Healthy earnings growth.
Solventum Corporation's yearly earnings has increased 224.84% since last year from $479.00M to $1.56G, signaling increasing performance
Increasing performance - Healthy revenue growth.
Solventum Corporation's yearly revenue has increased 0.86% since last year from $8.25G to $8.32G, signaling increasing performance
Increasing performance - ROIC.
ROIC 15.87% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Increasing performance - 3-year revenue CAGR.
Solventum Corporation's 3-year revenue CAGR of 0.79% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Solventum Corporation had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Solventum Corporation had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Solventum Corporation has insufficient data to evaluate this check.
Undervalued - Earnings yield.
Solventum Corporation has an earnings yield of 10.34%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
Solventum Corporation is overvalued relative to its fair value price of 78.89 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Solventum Corporation has an EV/EBITDA ratio of 6.64x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Undervalued - PEG ratio value.
Solventum Corporation has a PEG-ratio under 1 which is considered undervalued
Undervalued - P/B ratio.
Solventum Corporation has a price-to-book ratio of 2.79x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Solventum Corporation has a price-to-sales ratio of 1.67x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
30.71%
Return on equity
ROIC: 15.87%
Valuation History
9.7X
Price to Earnings
EV/EBITDA: 6.6X
Cash flow
Profit margin
2.72%
(FY vs FY)
EBITDA Y/Y
4.67%
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
EARNINGS FV (GRAHAM)
Fair Value
Market $77.15
44.71%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.